Everything is FREE until August 1free through July 31 →
Back to Blog
InjuryMLB2026-08-05

Brian Cashman Will Not Rule Out an Aaron Judge Season That Never Restarts

By Verdexed MLB Desk

Brian Cashman was asked directly this week whether it is possible Aaron Judge misses the remainder of the 2026 season, and the Yankees general manager did not rule it out. Cashman said the organization remains optimistic Judge will return, while acknowledging the challenges involved. That is the most pessimistic public framing the Yankees have offered since Judge went down.

Judge has not played since late May because of a right rib stress fracture. Imaging around the All-Star break showed healing that was not complete, and he has been limited to neck and lower-body work rather than baseball activities. No date has been set for the next round of imaging, which is the gating item for everything that follows.

Why the timeline keeps slipping

Rib stress fractures are among the least predictable injuries in baseball, and the reason is mechanical. Every component of a hitter's swing loads the rib cage, which means there is no partial return: a hitter is either cleared to swing or he is not. There is no equivalent of a pitcher's throwing progression that lets a player build back gradually while the bone continues to heal.

That produces the pattern the Yankees have been living with. Imaging shows partial healing, the player is held out, more time passes, and the next imaging date gets pushed because there is no benefit to scanning too early. Each cycle costs weeks, and the weeks compound.

The realistic outcomes now cluster in two places. Judge returns in late August or early September with two to four weeks to prepare for October, or he does not return at all. Cashman's refusal to rule out the second scenario is the first time the organization has acknowledged that publicly, and general managers do not volunteer that framing casually.

Fantasy fallout

For managers still holding Judge, the calculus has changed. A player who might return in September and might not is not an asset in a head-to-head league heading into the fantasy playoffs, because you cannot build a lineup around a maybe. In roto leagues where accumulation is what matters, the argument for holding is even weaker: a September return produces a handful of games and moves no category.

The honest read is that Judge is close to a drop in most redraft formats where roster spots are scarce. That is a difficult sentence to write about the best hitter in baseball, and it is the correct one given the calendar. If you have an injured-list slot that does not cost you an active roster spot, hold. If holding him costs you a usable bench player during the fantasy playoff push, the math no longer works.

The secondary effect runs through New York's lineup. Every Yankees hitter batting in the middle of the order has been operating without the game's most feared bat protecting or setting the table, and that shows up in pitch selection and run-scoring context. Those hitters have already absorbed the hit. What has not happened is a re-rating in the other direction: if Judge does return in September, the Yankees' surrounding bats get a meaningful late boost that most fantasy managers will not price in until it happens.

The Verdexed model take

Our rest-of-season projections apply a probability-weighted games-played estimate rather than a binary healthy-or-injured flag, which matters enormously for a case like this. Judge's projected remaining plate appearances have fallen steadily since the All-Star break, and Cashman's comments push the distribution further toward the low end.

What the model does not do is downgrade his per-plate-appearance production. Rib stress fractures do not carry the kind of lingering performance penalty that soft-tissue lower-body injuries or elbow issues do. If Judge plays, he should hit. The entire question is whether he plays.

On the team side, our Yankees projections have absorbed the absence for two months and are now essentially calibrated to a lineup without him. The upside scenario, a healthy Judge for the final three weeks and the postseason, is not fully priced into our team ratings, which creates an asymmetry worth noting.

Betting angle

That asymmetry is the actionable piece. Yankees World Series and pennant futures have been priced through two months of Judge's absence, and the market has largely stopped treating his return as a live possibility. If New York secures a playoff berth and Judge is cleared in September, the team that enters October is materially better than the team the futures market has been pricing.

That makes Yankees postseason futures a defensible contrarian position for bettors willing to accept genuine risk. The downside is straightforward: Judge does not return, and the ticket is dead money. The upside is a team with the best hitter in baseball entering a short series at a price set without him.

Avoid Judge season-long statistical props entirely. Home run and RBI totals for a player who has missed two months and may miss the rest are unpriceable in any direction, and any number still posted is more likely to reflect stale data than genuine value.

What's next

The next imaging appointment is the only meaningful marker, and the Yankees have not scheduled one publicly. When it happens, and when the results are described as full rather than partial healing, the clock on a return actually starts. Until then, every reported timeline is speculation.

Watch also for how the Yankees handle their roster over the next three weeks. A team that genuinely expects Judge back in September manages its outfield and designated hitter reps differently than one quietly planning without him. Roster behavior tends to be more honest than press conference language.

For now: hold Judge only in leagues where it is free, do not build a fantasy playoff roster around him, and keep an eye on Yankees futures if you are willing to bet on a medical outcome nobody can predict.

Want more analysis?

Check out our predictions and DFS tools powered by the same quantitative engine.